ethyl 5-(3-methoxyphenyl)-1H-pyrazole-4-carboxylate, 95.0%, 1g

Methyl 2-bromo-4-iodobenzoate, 97%, 5g

dNTP-Set 3, 5 x 4 x 25 µmol

Fmoc-DAP.HCl, 99.0%, 100g

5-(2-Methoxyethyl)-7-methyl-2,5,7-triazaspiro[3.4]octan-6-one hydrochloride, 95%, 50mg

4,6-Difluoro-2-methyl-1H-benzo[d]imidazole, 95.0%, 1g

Hexyl Ether>98.0%(GC)500mL

(3-Methyl-4-(piperidin-1-ylsulfonyl)phenyl)boronic acid, 97%, 1g

(R)-2-Acetamido-2-(2-fluorophenyl)propanoic acid, 95.0%, 100mg

2,6-Diaminoheptanedioic acid, 95.0%, 10g

3-Bromo-4-nitrobenzaldehyde, 98.0%, 10g

4,5-dimethylthiophene-3-carboxylic acid, 95.0%, 500mg

5-Methoxy-1-methyl-1H-benzo[d]imidazol-2(3H)-one, 95.0%, 100mg